An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 12 May 2017
At a glance
- Drugs Alogliptin (Primary) ; Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TRACK
- Sponsors Takeda
- 01 May 2017 Status changed from active, no longer recruiting to completed.
- 26 Apr 2017 Planned number of patients changed from 30 to 27.
- 26 Apr 2017 Planned End Date changed from 31 Mar 2017 to 30 Apr 2017.